The following are links to treatment guidelines for front-line and salvage therapy developed by several centers of excellence in the management of WM. Because there is no established standard of treatment, these guidelines may vary somewhat from one center to another.
"Treatment Recommendations for Waldenström Macroglobulinemia from the Eighth International Workshop on WM" Leblond, V., et al. Blood, September 8, 2016, Volume 128, Number 10.
These are updated treatment recommendations from the August 2014 International Workshop in London, England. (Article provided with permission of Dr. Steven Treon of the Bing Center for Waldenstrom's Macroglobulinemia.)
“Treatment recommendations for patients with Waldenström’s macroglobulinemia (WM) and related disorders: Consensus from the Seventh International Workshop on WM” Dimopoulos, M., et al. Blood, July 2014.
These are updated treatment recommendations based on the August 2012 International Workshop in Newport, Rhode Island.
"NCCN Clinical Practice Guidelines in Oncology for Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma".
The NCCN is a non-profit alliance of 23 cancer centers in the U.S. whose goal is to improve the quality and effectiveness of care provided to cancer patients. They provide updated guidelines based on the most current and up-to-date diagnosis and treatment guidelines available. You must establish an account on the NCCN website to login and view these guidelines.
"Diagnosis and Management of Waldenstrom Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines" Ansell, Stephen M., et al.
Mayo Clinic researchers provide their recommendations on timing and choice of therapy. These guidelines undergo periodic review and updating.
“How I Treat Waldenstrom Macroglobulinemia” Treon, S. P., Blood. First Edition Paper, prepublished online May 22, 2015, DOI 10.1182. Treatment recommendations published by Dr. Steven Treon of the Dana-Farber Cancer Institute in 2015. (Article provided with permission of the Bing Center for Waldenstrom's Macroglobulinemia.)